Showing 100,121 - 100,140 results of 123,774 for search '(( 2 d decrease ) OR ( 5 ((((mean decrease) OR (point decrease))) OR (a decrease)) ))', query time: 2.11s Refine Results
  1. 100121

    Megabase co-clustering of differential methylation between CPA (n = 8) and controls (n = 12). by Nadine Provençal (318748)

    Published 2014
    “…The olfactory receptor clusters located on chromosome 1 and chromosome 11 are less methylated in CPA compared to controls (scale log2 fold differences: −0.2 to 0.2). <b>C</b>. On chromosome 19, one of the few megabase regions showing decreased methylation in CPA compared to controls contains one of the two human micro-RNA clusters (scale log2 fold differences top and bottom panels: −0.2 to 0.2). …”
  2. 100122

    Supplementary Material for: Thromboelastography and Traditional Coagulation Testing in Non-ICU-Admitted Patients with Acute Kidney Injury: An Observational Cohort Study by Liu J. (3215370)

    Published 2023
    “…Heparin-free protocol was the strongest adverse factor to poor outcomes. A heparin-free subgroup analysis found that the circuit clotting risk was increased by 61.7% with a 10 × 10<sup>9</sup>/L elevation in platelet count (odds ratio [OR] = 1.617, <i>p</i> = 0.049) and decreased by 67.5% following a second increase of PT (OR = 0.325, <i>p</i> = 0.041). …”
  3. 100123

    Table 1_NOTCH1 and UPR signaling in embryonic heart development under maternal high-fat diet influence.doc by Yupeng Shi (1932442)

    Published 2025
    “…</p>Methods<p>C57BL/6J female mice were fed a HFD before and during pregnancy. Maternal blood was collected at P5.5, P10.5, and P14.5 to assess lipid levels. …”
  4. 100124
  5. 100125

    Differential effects of deletion in C99-PS1 wild type on Aβ40 and 42 production. by Naoyuki Sato (119858)

    Published 2012
    “…Arrow indicates C99-PS1R278I deletion product. <b>Panel C, D</b>: Analysis of Aβ40 level (left) and Aβ42 level (right) by Aβ ELISA in medium of PS1 (−/−) PS2 (−/−) cells transfected with C99-PS1 deletion mutants (C) or C99-PS1R278I (D). ** <i>p</i><0.01. …”
  6. 100126

    Image_4_The Association of Real-World CA 19-9 Level Monitoring Patterns and Clinical Outcomes Among Patients With Metastatic Pancreatic Ductal Adenocarcinoma.tif by Ben George (64738)

    Published 2021
    “…Patients with decreasing/stable CA 19-9 during treatment experienced longer survival than patients who experienced an increase in CA 19-9 levels [1L: 10.9 months (10.5 – 11.3) vs. 5.4 months (5.1 – 5.9), p < 0.0001; 2L: 8.2 months (7.7 – 8.5) vs. 4.3 months (4.1 – 4.7), p < 0.001; 3L: 7.5 months (6.6 – 9.2) vs. 3.7 months (3.4 – 4.3), p < 0.001].…”
  7. 100127

    Image_3_The Association of Real-World CA 19-9 Level Monitoring Patterns and Clinical Outcomes Among Patients With Metastatic Pancreatic Ductal Adenocarcinoma.tif by Ben George (64738)

    Published 2021
    “…Patients with decreasing/stable CA 19-9 during treatment experienced longer survival than patients who experienced an increase in CA 19-9 levels [1L: 10.9 months (10.5 – 11.3) vs. 5.4 months (5.1 – 5.9), p < 0.0001; 2L: 8.2 months (7.7 – 8.5) vs. 4.3 months (4.1 – 4.7), p < 0.001; 3L: 7.5 months (6.6 – 9.2) vs. 3.7 months (3.4 – 4.3), p < 0.001].…”
  8. 100128

    Image_1_The Association of Real-World CA 19-9 Level Monitoring Patterns and Clinical Outcomes Among Patients With Metastatic Pancreatic Ductal Adenocarcinoma.tif by Ben George (64738)

    Published 2021
    “…Patients with decreasing/stable CA 19-9 during treatment experienced longer survival than patients who experienced an increase in CA 19-9 levels [1L: 10.9 months (10.5 – 11.3) vs. 5.4 months (5.1 – 5.9), p < 0.0001; 2L: 8.2 months (7.7 – 8.5) vs. 4.3 months (4.1 – 4.7), p < 0.001; 3L: 7.5 months (6.6 – 9.2) vs. 3.7 months (3.4 – 4.3), p < 0.001].…”
  9. 100129

    Image_2_The Association of Real-World CA 19-9 Level Monitoring Patterns and Clinical Outcomes Among Patients With Metastatic Pancreatic Ductal Adenocarcinoma.tif by Ben George (64738)

    Published 2021
    “…Patients with decreasing/stable CA 19-9 during treatment experienced longer survival than patients who experienced an increase in CA 19-9 levels [1L: 10.9 months (10.5 – 11.3) vs. 5.4 months (5.1 – 5.9), p < 0.0001; 2L: 8.2 months (7.7 – 8.5) vs. 4.3 months (4.1 – 4.7), p < 0.001; 3L: 7.5 months (6.6 – 9.2) vs. 3.7 months (3.4 – 4.3), p < 0.001].…”
  10. 100130

    Box-and-whisker plots of the ICP by Lilit Harutjunyan (12654)

    Published 2011
    “…<p><b>Copyright information:</b></p><p>Taken from "Efficiency of 7.2% hypertonic saline hydroxyethyl starch 200/0.5 versus mannitol 15% in the treatment of increased intracranial pressure in neurosurgical patients – a randomized clinical trial [ISRCTN62699180]"</p><p>Critical Care 2005;9(5):R530-R540.…”
  11. 100131

    Average expression stability calculated by stepwise exclusion with geNorm for the reference genes. by Maurício Rocha-Martins (141086)

    Published 2012
    “…<p>Average expression stability values were obtained for each experimental set (Groups 1–5). Pairwise variation decreases from left to right, due to stepwise exclusion of the least stable reference gene. …”
  12. 100132

    <i>sod-3</i> expression correlates with remaining lifespan. by Adolfo Sánchez-Blanco (224518)

    Published 2011
    “…<p>(A) <i>sod-3::GFP</i> expression decreases in old worms. …”
  13. 100133

    Table_2_Identification of Cholecystokinin by Genome-Wide Profiling as Potential Mediator of Serotonin-Dependent Behavioral Effects of Maternal Separation in the Amygdala.XLSX by Magdalena T. Weidner (6689105)

    Published 2019
    “…<p>Converging evidence suggests a role of serotonin (5-hydroxytryptamine, 5-HT) and tryptophan hydroxylase 2 (TPH2), the rate-limiting enzyme of 5-HT synthesis in the brain, in modulating long-term, neurobiological effects of early-life adversity. …”
  14. 100134

    Table_3_Identification of Cholecystokinin by Genome-Wide Profiling as Potential Mediator of Serotonin-Dependent Behavioral Effects of Maternal Separation in the Amygdala.XLSX by Magdalena T. Weidner (6689105)

    Published 2019
    “…<p>Converging evidence suggests a role of serotonin (5-hydroxytryptamine, 5-HT) and tryptophan hydroxylase 2 (TPH2), the rate-limiting enzyme of 5-HT synthesis in the brain, in modulating long-term, neurobiological effects of early-life adversity. …”
  15. 100135

    Table_1_Identification of Cholecystokinin by Genome-Wide Profiling as Potential Mediator of Serotonin-Dependent Behavioral Effects of Maternal Separation in the Amygdala.XLSX by Magdalena T. Weidner (6689105)

    Published 2019
    “…<p>Converging evidence suggests a role of serotonin (5-hydroxytryptamine, 5-HT) and tryptophan hydroxylase 2 (TPH2), the rate-limiting enzyme of 5-HT synthesis in the brain, in modulating long-term, neurobiological effects of early-life adversity. …”
  16. 100136

    Data_Sheet_1_Identification of Cholecystokinin by Genome-Wide Profiling as Potential Mediator of Serotonin-Dependent Behavioral Effects of Maternal Separation in the Amygdala.pdf by Magdalena T. Weidner (6689105)

    Published 2019
    “…<p>Converging evidence suggests a role of serotonin (5-hydroxytryptamine, 5-HT) and tryptophan hydroxylase 2 (TPH2), the rate-limiting enzyme of 5-HT synthesis in the brain, in modulating long-term, neurobiological effects of early-life adversity. …”
  17. 100137

    Data_Sheet_2_Identification of Cholecystokinin by Genome-Wide Profiling as Potential Mediator of Serotonin-Dependent Behavioral Effects of Maternal Separation in the Amygdala.ZIP by Magdalena T. Weidner (6689105)

    Published 2019
    “…<p>Converging evidence suggests a role of serotonin (5-hydroxytryptamine, 5-HT) and tryptophan hydroxylase 2 (TPH2), the rate-limiting enzyme of 5-HT synthesis in the brain, in modulating long-term, neurobiological effects of early-life adversity. …”
  18. 100138

    Data_Sheet_3_Identification of Cholecystokinin by Genome-Wide Profiling as Potential Mediator of Serotonin-Dependent Behavioral Effects of Maternal Separation in the Amygdala.ZIP by Magdalena T. Weidner (6689105)

    Published 2019
    “…<p>Converging evidence suggests a role of serotonin (5-hydroxytryptamine, 5-HT) and tryptophan hydroxylase 2 (TPH2), the rate-limiting enzyme of 5-HT synthesis in the brain, in modulating long-term, neurobiological effects of early-life adversity. …”
  19. 100139

    Effects of KU-55933 and metformin on TCA metabolites. by Mahvash Zakikhani (118421)

    Published 2012
    “…<i>[d]</i> Both KU-55933 and metformin exposure lead to increased glucose uptake and lactate production, consistent with a compensatory increase in glycolysis following decreased oxidative phosphorylation. …”
  20. 100140

    Table1.docx by Maria S. Yusseppone (4876903)

    Published 2018
    “…Accumulation of succinate and induction of malate dehydrogenase (MDH) activity could indicate activation of anaerobic mitochondrial pathways to support anoxic survival in D. chilensis. Oxidative stress [protein carbonylation, glutathione peroxidase (GPx) expression] and apoptotic intensity (caspase 3/7 activity) decreased, whereas an unfolded protein response (HSP90) was induced under anoxia. …”